Lung function testing (LFT), diffusing capacity (DC) in patients with rheumatologic disorders: Is spirometry exclusionary?

G. Apti, H. Memis, A. Trailescu (Constanta, Bucharest, Romania)

Source: Annual Congress 2011 - Rare diffuse lung diseases
Session: Rare diffuse lung diseases
Session type: Thematic Poster Session
Number: 643
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Apti, H. Memis, A. Trailescu (Constanta, Bucharest, Romania). Lung function testing (LFT), diffusing capacity (DC) in patients with rheumatologic disorders: Is spirometry exclusionary?. Eur Respir J 2011; 38: Suppl. 55, 643

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of the lung volume measurement in the diagnosis of obstructive diseases in patients with restrictive ventilatory impairment
Source: International Congress 2014 – Alterations of exercise and lung function in different diseases
Year: 2014

Airspace dimension test (ADT): A novel technique for diagnosis of the peripheral lung
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014


Advance lung function testing: Lung Volumes(TLC) & Diffusing Capacity(DLco) diagnoses substantial pulmonary function impairment in treated Pulmonary Tuberculosis patients
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020


Does using the largest measured vital capacity in PFT intepretation help categorize patients out of the nonspecific pattern?
Source: International Congress 2014 – Alterations of exercise and lung function in different diseases
Year: 2014

Functional disorders in patients with COPD assessed by spirometry DLCO transfer characteristics, and plethysmography
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014


Impulse-oscillometry (IOS) differences in asthma and COPD patients, and healthy-subjects
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014


Do all COPD patients present irreversible airflow limitation?
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013

CT scan derived emphysema scores correlate with spirometry and gas exchange but not acute exacerbation rates (AER) or COPD assessment test (CAT) in COPD subjects with and without alpha-1-antitrypsin (AAT) deficiency
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013


Lung Clearance Index (LCI) and diffusion capacity of the lung (DLCO) in children with rheumatic disease
Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases
Year: 2020


The FEV1/TLC ratio: Can it differentiate between normal subjects and patients with airflow obstruction and restrictive ventilatory defects - a preliminary analysis?
Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation
Year: 2013

Quality of spirometry and diffusion of the lung (DLCO) data in patients with systemic sclerosis.
Source: International Congress 2019 – Insights into physiological diagnostic services
Year: 2019


How frequent are unusual types of ventilatory impairment (mixed and nonspecific)? Analysis of over 10,000 patients data
Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation
Year: 2013

Differences in functional impairment diagnosis using global lung initiative (GLI) predictive values for spirometry
Source: International Congress 2014 – The impact of the Global Lung Initiative (GLI) reference equations and spirometry quality in all ages
Year: 2014


Volumetric capnography in distinct phenotypes of COPD patients
Source: International Congress 2016 – Lung function and imaging: new findings and new approaches
Year: 2016


The airspace dimension test – A new way to diagnose emphysema?
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014

Clinical characteristics, pulmonary function, and response to beta2-agonist: Patients with asthma vs. patients with asthma/COPD overlap syndrome
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013


Ventilation heterogeneity in COPD and healthy smokers relates to diffusion capacity, resistance and reactance
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015


Flow-volume parameters in COPD related to extended measurements of lung volume, diffusion and resistance
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013


The global Lund function initiative (GLI) reference values do not reflect lung function in the Nordic countries
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015

The effects of standard therapy for COPD patients on FEV1 are associated with lower score of the Goddard classification
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014